Solcoseryl Protein-Free Hemodialysate: A Natural Enhancer for Cellular Health and Regeneration Processes

Solcoseryl is a unique medical product derived from protein-free hemodialysate of dairy calves. It is enriched with ingredients commonly found in cells and blood serum. Its main purpose is to increase the delivery of oxygen and glucose to cells, especially when they are deficient in oxygen. Through this action, solcoseryl promotes cellular energetics, supporting the body's natural regeneration processes. In addition, it plays a key role in skin rejuvenation and maintaining the integrity of blood vessels.

Solcoseryl is available in various forms, such as injectable liquid, gel or cream. There is also a special version for oral problems, such as painful gums or lips. People reach for this drug to relieve various skin problems and for oral care.

Benefits of using solcoseryl: Based on medical studies

Solcoseryl has demonstrated efficacy in a variety of conditions - from accelerating wound healing and relieving gingival inflammation to optimizing neurological function. How can solcoseryl be an innovative therapeutic agent in various medical fields?

Benefits of solcoseryl for the brain and nervous system

Solcoseryl has shown promising results in numerous scientific studies that have focused on its potential benefits for brain and nervous system health. From reducing brain damage caused by bleeding to enhancing learning and memory processes in animal models.

Reduced brain damage: Studies show that solcoseryl may be helpful for people experiencing bleeding in the brain caused by a blood vessel rupture, known as an aneurysm. In one study, 300 patients with arterial aneurysms received solcoseryl, while 50 received no treatment. The results showed that the group receiving solcoseryl showed better recovery. These patients achieved better outcomes 30 days after brain injury. They achieved fewer serious health problems and deaths compared to the group not receiving the drug. This suggests that solcoseryl may help alleviate the negative effects of bleeding in the brain caused by ruptured arteries [1].

Preventing nerve ulcers: solcoseryl in combination with Proglumide can effectively prevent nerve ulcers in patients with significant kidney problems. In a scientific study, patients with significant kidney problems after surgery or trauma were given solcoseryl (in combination with Proglumide) as a means of preventing nerve ulcers. The results of the study showed that patients receiving this treatment were less likely to develop ulcers compared to the group that did not receive this drug combination [2].

Modulation of brain activity: an animal study suggests that solcoseryl positively affects brain activity. It was shown that at specific times and doses, the administration of solcoseryl affected the movements and sleep patterns of rats. For example: it reduced sleep time when given 15 minutes before another drug. These results suggest that solcoseryl may have the ability to modulate brain activity and influence certain behaviors [3].

Improving learning and memory: Another study in rats indicates that solcoseryl may have a beneficial effect on learning and memory processes. Solcoseryl was found to improve both the "acquisition" phase of new information and its subsequent recall. For certain tasks, different doses showed specific positive effects, suggesting solcoseryl's potential to enhance brain function related to learning and memory [4].

Helping with cerebral ischemia: solcoseryl combined with acupuncture may benefit cerebral ischemia. An animal study showed that a combination of solcoseryl and acupuncture had better results in reducing symptoms than using each treatment separately. Specifically, this combined approach significantly reduced problems observed in the cerebral ischemia model, such as high rates of neurological deficit and increased water and lactic acid content in the brain [5].

Potential benefits in treating blood circulation problems in the brain

Promising treatments for adverse cerebrovascular conditions

solcoseryl has been studied in the context of its effects on patients with early or ongoing cerebrovascular problems, conditions related to blood circulation in the brain. The study included 29 patients. Some of them struggled with vegetovascular dystonia, affecting the blood vessels and nervous system, and others with varying degrees of dyscratic encephalopathy, affecting brain function due to blood circulation problems. The results showed a positive effect of solcoseril. Patients experienced fewer and shorter episodes of vegetovascular problems, and reported better general well-being. This suggests that solcoseryl may be a beneficial approach to managing conditions related to blood circulation in the brain [6, 6A].

Significant benefits for Cerebrovascular Insufficiency (CVI)

Cerebrovascular anemia, known as CVI, is a condition in which blood supply to the brain is reduced. An extensive study was conducted. It involved 243 patients who received daily injections of solcoseril (2.0 ml each) for 25 days, and this treatment was repeated twice a year. The results showed a marked reduction in neurological symptoms. Patients were also given medications to regulate blood pressure and prevent blood clots. The combination of solcoseril with other drugs resulted in a significant reduction in the patients' risk of deterioration, as well as a reduction in the number of incidents of temporary blood supply disruptions and strokes compared to those treated with standard methods. These findings suggest that solcoseryl may be an important component in the treatment of CVI, enhancing the benefits of other therapies and improving the overall health of patients [7].

As such, solcoseryl may provide relief for patients with blood circulation problems in the brain. Its benefits range from reducing symptoms, improving overall health and lowering the risk of more serious complications. The above results underscore solcoseryl's potential as an effective therapeutic agent for neurological problems.

Healing properties of Solcoseryl

Recent scientific studies indicate that solcoseryl plays a significant role in accelerating and effectively supporting recovery from various types of injuries.

Solcoseryl for eye health

Solcoseryl is gaining prominence in the field of ophthalmic care, offering a range of benefits for various eye conditions. From dry eyes to corneal damage. The therapy is showing promising results in relieving symptoms and promoting healing. The following are scientific studies that illustrate the potential role of solcoseryl in ocular disorders.

Eye injury healing

A study of the effectiveness of "solcoseryl Eye-Gel" compared to "Cysteine Eye-Gel" for corneal injuries. Solcoseryl proved to be the more effective choice. After treatment with solcoseryl gel, its effect on tissue regeneration and increased cellular oxygen uptake was noted. Over the course of treatment, as many as 63% of patients using solcoseryl saw complete healing of their epithelial injuries, compared to only 53% for Cysteine Eye-Gel. This suggests that solcoseryl accelerates the recovery process after corneal injuries and benefits eye health [17].

Increased humidity and dry eye healing

A comparative study between "solcoseryl eye drops" and "Vitasic eye drops" showed that solcoseryl achieved better results. In participants with corneal erosion and dry eye syndrome, solcoseryl not only accelerated the healing process, but also increased eye moisture. The statistically significant improvement establishes the formulation as a more effective treatment option for these eye conditions [18].

Improved corneal wound healing with Solcoseryl

In a controlled, double-blind study involving 61 patients with corneal injuries, "solcoseryl Eye-Gel" was tested against 2.4% cysteine eye gel. The eyes of patients treated with solcoseryl Eye-Gel not only healed faster, but were also less likely to develop corneal macula temidoj after the healing process was complete [19].

Accelerated corneal healing after foreign body removal with Solcoseryl

The double-blind study evaluated the effect of solcoseril on corneal healing, particularly after foreign body removal. Those treated with solcoseril showed faster healing than the control group. In addition, the solcoseril-treated group was less likely to develop corneal opacity. The lack of negative side effects associated with the use of solcoseril underscores its potential for effective corneal healing after foreign body removal [20].

Help with chronic dry eye syndrome

Solcoseryl has proven to be a versatile solution for a variety of eye problems. In a study involving 18 patients with chronic dry eye syndrome, solcoseryl gel proved extremely helpful. Not only did it promote healing of the corneal surface, but it also increased the transparency of the cornea. Compared to another treatment, i.e. 2,4% ophthalmic gel with cysteine, solcoseryl showed better efficacy, especially in patients with dry keratitis, due to better tolerability [21].

Good for contact lens wearers with dry eyes

Contact lens wearers often experience discomfort from dry eyes and associated corneal damage. In a study involving contact lens wearers with dry eyes, of the 66 participants, those who added solcoseryl to their treatment along with Corneregel saw significant benefits. Within 7 to 14 days, many noticed corneal healing. For those with more advanced damage, the introduction of solcoseryl further improved the cornea, providing additional comfort for lens wearers. This combination not only resulted in regeneration of the corneal surface, but also had a positive effect on the anterior layer of the eye, providing both health and comfort for lens wearers [22].

Help with cases of vascular problems in the eyes

For people with vascular problems in their eyes, solcoseryl may prove to be a savior. In a scientific study spanning more than 17 years with 2331 patients, solcoseryl treatment led to increased visual function, improved retinal blood vessel function, and provided lasting improvement. Impressively, the recovery time for patients undergoing solcoserol treatment is reduced [23].

Summary

In each of these cases, solcoseryl is shown to be a helpful treatment for a variety of eye problems, helping to improve patients' vision and overall well-being.

Solcoseryl for cardiovascular health

Solcoseryl has shown potential in improving cardiovascular health. A number of studies have shown the beneficial effects of solcoseryl in patients facing a variety of cardiovascular conditions. These range from aiding recovery after heart attacks to treating peripheral vascular disease. The product has demonstrated efficacy and a potential role in comprehensive cardiac care.

Faster recovery after heart attack thanks to Solcoseryl

In a study involving 58 patients with acute myocardial infarction, solcoseryl was used to evaluate its effect on recovery. The results were promising: patients treated with solcoseryl reported fewer episodes of angina, suggesting a reduction in heart pain. Those treated with solcoseryl showed faster recovery from CHF symptoms and improved ability to perform physical activity [24].

Calf blood dialysate (Solcoseryl/Actovegin) after myocardial infarction

In another study involving 60 people after myocardial infarction, calf blood dialysate (solcoseryl/Actovegin) lowered the levels of specific enzymes in their blood, such as creatine kinase and aspartate aminotransferase, where both indicate a reduction in cardiac damage. This suggests that calf blood dialysate may offer some potential cardiovascular benefits [25].

Solcoseryl in a multifaceted approach to treating chronic heart disease

Patients with chronic coronary heart disease (CHD) may benefit from a therapeutic approach involving solcoseryl. A large study involving 349 CHD patients used therapies combining He-Ne laser radiation, alpha-tocopheryl acetate and solcoseryl. Results indicated that solcoseryl, in combination with these therapies, significantly relieved pain and improved exercise tolerance. Importantly, the formulation also showed significant efficacy against arrhythmias, highlighting its potential role in the comprehensive treatment of heart disease [26].

The effect of Solcoseryl on atherosclerosis

For people with chronic atherosclerosis of the lower extremities, calf blood dialysate may offer hope. A study of 158 such patients revealed that after treatment with solcoserol, as many as 93% experienced improvements in quality of life, sustained for at least six months. In addition, minimal doses of aspirin and nicotinic acid were found to be effective as maintenance therapy in between treatment cycles [27].

Treatment of peripheral vascular disease with solcoseryl

Peripheral arterial disease is a serious vascular disorder. The condition of patients with this disease significantly improved after treatment with solcoseryl. Not only did the symptoms and visible signs of the disease improve, but also the oxygen level, which was previously lowered due to the disease. There was also an increase in the difference between arterial and venous oxygen levels. Lactic acid levels decreased, indicating the role of solcoseryl in improving oxygen transport and utilization, especially in areas affected by the disease [28].

Solcoseryl's potential in treating ulcers

Shortened ulcer treatment time with Aevitum and Solcoseryl

A large study involving 105 patients with peptic ulcers used a combination of aevitum and solcoseryl. The methods of administering solcoseryl varied, but the group receiving direct injections experienced rapid healing, with their ulcers completely healed in just 10-12 days, a significant breakthrough [29].

Reduced healing time and frequency of recurrence with Solcoseryl and Statizol

Another study, on 300 ulcer patients, used a combination of solcoseril and "statizol." The results were promising, cutting the healing time in half and significantly reducing the recurrence rate of ulcers. The recurrence rate was much lower in the group receiving this combined treatment compared to the control group [30].

Faster recovery from ulcer surgery with solcoseryl

Patients undergoing ulcer surgery and receiving solcoseryl by injection experienced earlier relief from pain, reduced inflammation and smoother recovery. In addition, they were able to be discharged from the hospital 3-5 days earlier than expected, reducing the cost of their stay and speeding up their return to normal life [31].

Solcoseryl appears to play an important role in shortening healing time and reducing ulcer recurrence, a promising prospect for those suffering from the condition.

Better healing in rats with Solcoseryl and Cycloferon

Experimental studies on male rats showed that the combination of solcoseril with cyclopherone, an interferon inducer, had promising healing properties. Rats treated with the combination showed better healing of duodenal ulcers compared to those treated with each drug separately [32]. These results suggest the potential of solcoseryl in ulcer management, especially when used in combination with other drugs.

Oral health benefits

Accelerated healing of oral wounds

The researchers used a unique dental film, Diplan-denta C, containing solcoseryl, to accelerate healing of surgical wounds on the inside of the cheek. Comparing this to conventional treatments, the Diplan-denta C film accelerated the healing of buccal mucosal injuries, suggesting a potential role for solcoseryl in the healing process [33].

Support for patients with hypertension

The study examined how "solcoseryl-Denta" cream assists hypertensive patients undergoing oral prosthetic procedures. The use of the cream accelerated the healing of the oral mucosa, which significantly reduced the risk of complications after the procedure [34]. This suggests that solcoseryl may play a role in improving oral health, especially for patients undergoing dental procedures.

Treatment for severe gum disease

In a study with people suffering from a severe form of gum disease, solcoseryl was injected into the gums, showing promising results. There was a significant reduction in inflammation, bleeding and fluid in specific areas of the gums. Although it did not significantly affect tooth mobility or pocket depth, this suggests that the substance may have a beneficial effect on symptoms associated with severe gum disease [35].

Pain-free recovery after gum surgery

For some bridgework, Solcoseryl Dental Adhesive Paste has proven to be a key component in post-operative care, enabling pain-free recovery [36].

Prevention of dry socket after tooth extraction

A study that used a combination of gelatin and solcoseryl after tooth extraction aimed to counteract "dry socket," a painful postoperative condition. The group treated with the preparation recorded a significant reduction in the number of cases of dry socket, suggesting a potential role for the substance in preventing this painful post-extraction complication [37].

Musculoskeletal Benefits

Solcoseryl also appears to benefit the musculoskeletal system, particularly bone health and joint pain relief.

Femur strengthening

A study in young rats suggests that solcoseryl may affect the strength of the femur, increasing its toughness. In addition, it appears to counteract the debilitating effects of some drugs, highlighting its potential role as a bone-strengthening substance [38].

Pain relief in knee osteoarthritis

In a study on patients with knee osteoarthrosis, injections of solcoseryl/actovegin directly into the knee joints resulted in a decrease in pain. Patients experienced an average decrease in VAS scores and an average reduction in pain scores. The lack of reported side effects suggests that this treatment may not only be effective, but also safe. Nevertheless, further studies are needed to confirm these promising results [39].

Improving bone formation around dental implants

The process of osseointegration is crucial for the successful placement of dental implants. There has been some interesting research on the potential role of solcoseryl in this area. Conducted on rabbits, the study focused on combining calf blood dialysate with a capacitively coupled electric field (CCEF) technique, aiming to explore the possibility of increasing bone growth around dental implants. The results are promising, as bone formation and strength in the implant area were significantly improved using both solcoseril and CCEF. These results suggest that combining these two treatments can significantly improve the success of dental implants [40].

Based on these observations, it appears that solcoseryl may play a key role in promoting musculoskeletal health. Its potential not only to strengthen bones, but also to relieve joint pain and improve the effectiveness of dental implants makes it a versatile ingredient in the orthopedic and dental therapy fields.

Solcoseryl in the treatment of various medical conditions

Scientific studies show the potential of solcoseryl in the treatment of a variety of medical conditions, from lower extremity preganglion to severe head injuries. Its various mechanisms of action include improving chemical processes in the body, reducing inflammation, promoting tissue healing and potentially protecting against tissue damage.

Treatment of preganglion of the lower limb

Gangrene, resulting from ischemia and infection, poses a serious threat to the body's tissues. In the study conducted - solcoseryl applied topically to the affected areas accelerated the healing process and promoted the regeneration of tissues affected by gangrene. The results were promising, with the group using solcoseryl achieving significantly better results compared to the placebo group. The treatment showed efficacy through noticeable improvements in the early symptoms of gangrene, such as skin color changes, pain and swelling in the lower extremities [41].

Support for severe head injuries

Solcoseryl has been used in cases of severe head trauma, particularly closed craniocerebral injuries. Administered intravenously in conjunction with antioxidant therapy, it worked by increasing oxygen utilization in damaged brain tissue. In combination with antioxidants, the drug directly influenced inflammatory processes, resulting in significant patient benefits, such as improved neurological status and stabilization of blood pressure [42].

Help treat leg ulcers in patients with sickle cell anemia

Sickle cell anemia is characterized by distorted red blood cell morphology, which can lead to various complications, including ulcers. A study conducted on patients with sickle cell anemia showed that topical application of solcoseryl to ulcers resulted in visible healing. The mechanism of action of solcoseryl, based on promoting cellular regeneration and wound healing, contributed to a significant improvement in the condition of patients with the disease [43].

Potential in the treatment of chronic bronchitis

In patients with chronic bronchitis, the combination of solcoseryl with other treatments has shown efficacy in improving symptoms and certain biochemical markers associated with the disease. Acting by increasing oxygen delivery and utilization in the lungs, solcoseryl helped relieve symptoms and made positive changes in biochemical markers associated with chronic bronchitis. These findings suggest the potential of solcoseryl to increase the efficacy of overall bronchitis treatment [44].

Protection against liver damage

Liver damage can lead to serious conditions such as liver fibrosis and cancer. In a study on protection against liver damage, a protein-free calf blood extract (solcoseryl/actovegin) was likely administered orally to mice. The results suggest that the compound protects cells and promotes liver cell regeneration, highlighting its potential benefits in liver protection in humans as well [45].

Positive effects in late pregnancy

In cases of chronic placental insufficiency in late pregnancy, solcoseryl has shown the potential to increase estrogen excretion, a key hormone during pregnancy [46]. Taking solcoseryl intravenously or orally, tailored to the stage of pregnancy and degree of placental insufficiency, led to a significant increase in estrogen secretion, which may be key to maintaining a healthy pregnancy [46].

Management of chronic placental insufficiency

In cases of chronic placental insufficiency, which can lead to inadequate blood flow to the fetus, solcoseryl administered intravenously helped increase placental blood flow to support nutrient delivery. Dosage was adjusted according to the progress of the pregnancy and the degree of insufficiency. The results suggest that the use of solcoseryl may improve placental function, which is important in maintaining a healthy pregnancy [47].

Management of oxidative stress in pregnancy complications

Oxidative stress in pregnancy complications can adversely affect the health of mother and baby. Solcoseryl, administered orally or intravenously in pregnant women with a diagnosis of intrauterine growth retardation (IUGR), has been used to manage oxidative stress. Dosage was adjusted according to the diagnosis and degree of IUGR. Solcoseryl balances oxidative processes, which led to a significant reduction in oxidative stress markers in pregnant women with IUGR [48].

Possible mechanisms of action of solcoseryl

Solcoseryl exhibits a complex mechanism of action, making it a versatile therapeutic agent with applications in various medical conditions. Derived from a deproteinized hemoderivative, its primary function includes enhancing tissue regeneration and improving cellular oxygen utilization.

Neurological status

Solcoseryl helps minimize permanent damage from brain hemorrhages.
Modulates central nervous system activity, improving outcomes in cerebrovascular disease.
Reduces the risk of disease progression and transient ischemic attacks.
Positively affects learning and memory in animal models.

Digestive system healing

Effective in accelerating epithelial cell regeneration in corneal injuries, gummy wounds and deep wounds.

Cardiovascular disease and peripheral vascular disease

It contributes to improved hemodynamics.
Supports faster recovery from circulatory failure.

Interaction with other treatments

Increases interferon responses.
Supports antioxidant defense.

Wound care applications

Effective in accelerating epithelial cell regeneration in various types of wounds.

Gene expression and signaling pathway regulation

Increases the expression of specific genes and intracellular signaling pathways.

Summary

Solcoseryl appears to be a versatile drug with a wide range of applications, covering different areas of medicine. Studies suggest that it may have benefits in improving brain function, accelerating wound healing, supporting eye health, and positively impacting heart health. It is a substance that appears to have the potential to help in many different areas of health, making it a broad-spectrum tool in medical practice.

Disclaimer

This article was written for educational purposes and is intended to raise awareness of the substance under discussion. It is important to note that the article is about the substance in general - it is not a description of a specific product (chemical reagent). We do not suggest using chemical reagents on humans - this is prohibited by law. For a product to be used for treatment, it must be registered as a drug. The information in the text is based on available scientific research and is not intended to serve as medical advice or promote self-medication. The reader should consult any health and treatment decisions with a qualified health professional.

 

References

1. Dziak, L. A., & Golik, V. A. (2001). Experience gained with Solcoseryl as treatment of patients with cerebral hemorrhage. Likars'ka sprava, (4), 162–168. https://pubmed.ncbi.nlm.nih.gov/11692704/
2. Bouletreau, P., Petit, P., & Motin, J. (1976). Stress ulcer and acute postoperative renal insufficiency. Attempt at preventive treatment with Solcoseryl and proglumide. Annals of French Anesthesiology, 17(5), 585–590. https://pubmed.ncbi.nlm.nih.gov/10798/
3. Braszko, J. J., Winnicka, M. M., & Wiśniewski, K. (1996). Solcoseryl stimulates behavioral activity of rats. Acta Physiologica Hungarica, 84(1), 63–72. https://pubmed.ncbi.nlm.nih.gov/8993676/
4. Winnicka, M. M., Braszko, J. J., & Wiśniewski, K. (1996). Solcoseryl improves learning and memory in rats. Acta Physiologica Hungarica, 84(1), 55–62. https://pubmed.ncbi.nlm.nih.gov/8993675/
5. Wang, Y. M., Gao, J. H., Yu, X. C., Wang, S. X., & Wang, H. X. (2009). Acupuncture Research, 34(1), 9–12. https://pubmed.ncbi.nlm.nih.gov/19526800/
6. Rudenko, A. Iu., & Bashkirova, L. M. (2003). Solcoseryl—a new means of pathogenetic treatment for patients with paroxysmal conditions in cerebrovascular pathology. Likars'ka sprava, (7), 110–113. https://pubmed.ncbi.nlm.nih.gov/14723151/
7. Kurako, I. L., Gertsev, N. F., Gertsev, V. N., Vishnevskiĭ, V. S., Stoianov, A. N., & Chemeresiuk, I. G. (2004). Preliminary data on low-dose Solcoseryl in dyscirculatory encephalopathy. Likars'ka sprava, (1), 79–80. https://pubmed.ncbi.nlm.nih.gov/17051721/
8. Chukanova, E. I., & Bogolepova, A. N. (2007). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, Suppl 21, 57–64. https://pubmed.ncbi.nlm.nih.gov/18927981/
9. Nam, S. M., & Maeng, Y. S. (2019). Wound healing and mucin gene expression of human corneal epithelial cells treated with deproteinized extract of calf blood. Current Eye Research, 44(11), 1181–1188. https://doi.org/10.1080/02713683.2019.1633360
10. Studer, O. (1984). Solcoseryl Eye-Gel vs Cysteine Eye-Gel in corneal injuries. Ophthalmic Research, 16(3), 179–184. https://doi.org/10.1159/000265314
11. Dymkowska, W., & Malarewicz, A. (1980). Fluorescence microscopy in gingival wound healing. Dentistry of the GDR, 30(4), 261–269. https://pubmed.ncbi.nlm.nih.gov/6161451/
12. Wilmink, J. M., Stolk, P. W., van Weeren, P. R., & Barneveld, A. (2000). Solcoseryl in equine wound healing. Journal of Veterinary Medicine A, 47(5), 311–320. https://doi.org/10.1046/j.1439-0442.2000.00287.x
13. Imran, H., Ahmad, M., Rahman, A., Yaqeen, Z., Sohail, T., Fatima, N., Iqbal, W., & Yaqeen, S. (2015). Wound healing comparison with Salvadora persica. Pakistan Journal of Pharmaceutical Sciences, 28(5), 1777–1780. https://pubmed.ncbi.nlm.nih.gov/26408876/
14. Abakarova, D. S. (2004). Solcoseryl film in oral mucosal injury. Dentistry, 83(4), 33–36. https://pubmed.ncbi.nlm.nih.gov/15340302/
15. Pavliuk, B., Stechyshyn, I., Kramar, S., Chubka, M., & Hroshovyi, T. (2021). Burn wound regeneration with gel. Polish Medical Courier, 49(293), 352–355. https://pubmed.ncbi.nlm.nih.gov/34800022/
16. Miyaji, H., Sakurai, H., Kikawada, M., et al. (2005). Japanese Journal of Geriatrics, 42(1), 90–98. https://doi.org/10.3143/geriatrics.42.90
17. Ibishov, K. G. (1999). Ultrasonic abdominal cleansing in gunshot wounds. Journal of Surgery, 158(2), 40–42. https://pubmed.ncbi.nlm.nih.gov/10368889/
18. Krannig, H. M., Rohde-Germann, H., & Straub, W. (1989). Therapy of corneal erosions. Ophthalmology, 199(2–3), 100–105. https://doi.org/10.1159/000310024
19. Erbe, W., Herrmann, R., Körner, W. F., et al. (1984). Solcoseryl Eye-Gel in corneal lesions. Ophthalmology, 188(1), 1–4. https://doi.org/10.1159/000309336
20. Haydon, P. (1983). Solcoseryl gel with antibiotics in corneal healing. Clinical Monthly Journal of Ophthalmology, 183(3), 213–216. https://doi.org/10.1055/s-2008-1054907
21. Krzystkowa, K. M., Hydzikowa, M., & Szpytma, R. (1991). Solcoseryl ophthalmic gel trial. Eye Clinic, 93(6), 162–163. https://pubmed.ncbi.nlm.nih.gov/1942917/
22. Egorova, G. B., Mitichkina, T. S., & Shamsudinova, A. R. (2014). Vestnik of ophthalmology, 130(2), 59–67. https://pubmed.ncbi.nlm.nih.gov/24864502/
23. Eliseeva, E. G., Vorob’eva, O. K., & Astaf’eva, N. V. (1999). Treatment of fundus vascular pathology. Vestnik of ophthalmology, 115(6), 37–38. https://pubmed.ncbi.nlm.nih.gov/10665289/
24. Leshchinskiĭ, L. A., Pimenov, L. T., Kalinina, S. A., & Kolodkin, D. E. (1990). Solcoseryl in myocardial infarction. Cardiology, 30(4), 37–40. https://pubmed.ncbi.nlm.nih.gov/2203929/
25. Calf blood dialysate in myocardial infarction. Clinical Trials and Meta-Analysis, 28(1), 13–21. https://pubmed.ncbi.nlm.nih.gov/10148188/
26. Luk'ianov, Iu. V., et al. (2000). Solcoseryl in arteriosclerosis obliterans. Journal of Surgery, 159(3), 81–84. https://pubmed.ncbi.nlm.nih.gov/10983350/
27. Rossano, C., Weiner, M., & Haigis, E. (1990). Peripheral vascular disease treatment. Arzneimittel-Forschung, 40(11), 1195–1200. https://pubmed.ncbi.nlm.nih.gov/2085330/
28. Granov, A. M., et al. (1989). Gastroduodenal ulcer treatment. Journal of Surgery, 144(12), 12–15. https://pubmed.ncbi.nlm.nih.gov/2700609/
29. Tsarev, N. I., & Krasnykh, A. M. (1989). Endoscopic ulcer therapy. Journal of Surgery, 142(3), 28–31. https://pubmed.ncbi.nlm.nih.gov/2665305/
30. Fomin, P. D., et al. (1998). Solcoseryl after ulcer surgery. Clinical Surgery, (12), 6–8. https://pubmed.ncbi.nlm.nih.gov/10077934/
31. Bul'on, V. V., et al. (2001). Cycloferon in duodenal ulcers. Experimental and Clinical Pharmacology, 64(6), 41–44. https://pubmed.ncbi.nlm.nih.gov/11871237/
32. Jedrzejewska, T., Bałczewska, E., Peterson, R., Urbaniak, B., & Ostrowska, B. (1990). Periodontal disease treatment. Dental Journal, 43(6), 366–370. https://pubmed.ncbi.nlm.nih.gov/2104369/
33. Bakalian, V. L. (2009). Georgian Medical News, (172–173), 39–42. https://pubmed.ncbi.nlm.nih.gov/19644187/
34. Schatz, J. P., Fiore-Donno, G., & Henning, G. (1987). Fibrinolytic alveolitis prevention. International Journal of Oral and Maxillofacial Surgery, 16(2), 175–183. https://doi.org/10.1016/s0901-5027(87)80127-3
35. Nadulska, A., Klukowska, L., & Dyba, S. (2000). Bone strength study in rats. UMCS Annals Medicine, 55, 189–192. http://bc.umcs.pl/Content/43265/czas4054_55_2000_29.pdf
36. Kuptniratsaikul, V., & Kuptniratsaikul, S. (2004). Intra-articular injection in osteoarthritis. Journal of the Medical Association of Thailand, 87(1), 100–105. https://pubmed.ncbi.nlm.nih.gov/14971542/
37. Ochi, M., Wang, P. L., Ohura, K., et al. (2003). Bone formation around implants. Clinical Oral Implants Research, 14(3), 294–302.